United States, Rockville MD, Aug. 05, 2022 (GLOBE NEWSWIRE) -- The global drug discovery technologies market accounts for a valuation of US$ 59 billion in 2022 and is slated to increase at a CAGR of 8.4% over the next four years. These insights have been released in the latest drug discovery technologies market research survey performed by analysts at Fact.MR, a market research and competitive intelligence provider.
Rising incidence of chronic diseases has led to increased demand for drugs and this trend is expected to be rife over the forecast period and drive overall drug discovery technologies market growth. Rising focus on healthcare has resulted in increased spending in the research and development sector, which is expected to fuel demand for drug discovery technologies across the world.
However, high costs and stringent regulatory norms regarding drug development are expected to have a hindering effect on overall market potential.
For More Insights on this Market, Get A Sample Report!
Drug discovery technology companies are expected to launch novel products with advanced capabilities to boost the efficiency of the drug development process, and there will be increased demand for biologic drugs.
- In July 2022, Curi Bio, a renowned developer of human stem cell-based platforms for drug discovery, announced the launch of a discovery platform for therapeutics. The Mantarray™ Platform enables the discovery of new therapeutics by facilitating the analysis of 3D Engineered Muscle Tissues (EMTs).
Key Takeaways from Market Study
- Currently, the global drug discovery technologies market stands at US$ 59 billion.
- From 2022 to 2026, demand for drug discovery technologies is set to evolve at a CAGR of 8.4%.
- By 2026, the drug discovery technologies market is set to reach US$ 81.5 billion in value.
- Increasing incidence of chronic diseases, rising investments in R&D activities, growing demand for drugs, and technological advancements are prime factors expected to drive drug discovery technologies market growth.
- In 2022, the U.S. drug discovery technologies market accounts for a revenue of US$ 17 billion.
- High costs and strict regulatory mandates are expected to have a restraining effect on market potential over the coming years.
- The China drug discovery technologies market is projected to expand at a CAGR of 10% to reach US$ 12 billion by 2026.
- The market for drug discovery technologies in Germany is set to evolve at a CAGR of around 7% over the forecast period.
"Increasing R&D activities and rising demand for novel drugs are expected to influentially propel drug discovery technologies market growth through 2026," says a Fact.MR analyst
To Gain In-Depth Insights on Drug Discovery Technologies Market, Request Methodology at
Drug discovery technology providers are expected to widen their research scope by investing in more R&D activities. Market players are expected to adopt various strategies such as collaborations and partnerships to fast-track the launch of new products and widen their research scope.
Competitive Landscape :
Companies in the drug discovery technologies market are expected to focus on launching new solutions to enhance drug discovery and drug development.
- In July 2022, Dotmatics, an R&D scientific software organization, announced the release of its new Chemistry Solution for Small Molecule Drug Discovery. The new solution is a compilation of workflows, R&D applications, and the company's enterprise scientific platform to provide best practices for small molecule drug discovery and development.
Segments of Drug Discovery Technologies Industry Research
- By Drug Type :
- Small Molecule Drugs
- Biologic Drugs
- By Technology :
- High Throughput Screening
- Bioanalytical Instruments
- Nanotechnology in Drug Discovery
- Other Technologies
- By End User :
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Biotechnology Companies
- Research Institutes
- Other End Users
- By Region :
- North America
- Latin America
- East Asia
- South Asia & Oceania
Interested to Procure The Data? Inquire here
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global drug discovery technologies market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2026.
The study divulges essential insights on the market on the basis of type (small molecule drugs, biologic drugs), technology (high throughput screening, genomics, biochips, pharmacogenomics, bioanalytical instruments, bioinformatics, nanotechnology in drug discovery, other technologies), and end user (pharmaceutical companies, biopharmaceutical companies, biotechnology companies, research institutes, other end users), across six major regions (North America, Latin America, Europe, East Asia, South Asia & Oceania, and the Middle East & Africa).
Explore Fact.MR's Coverage on the Healthcare Domain-
Ophthalmic Ultrasound Devices Market - Ophthalmic Ultrasound Devices Market by Product (B-Scan, A-Scan, Combined, Pachymeter, Ultrasound Bio Microscope), By Mobility (Portable, Standalone), By End Use (Hospitals, Ambulatory Surgery Centers, Ophthalmology Clinics, Others), and by Region - 2022 to 2032
Reprocessed Medical Devices Market - Reprocessed Medical Devices Market Analysis by Device Type (Cardiovascular Devices, General Surgery Devices, Laparoscopic Devices, Orthopedic External Fixation Devices, Gastroenterology Biopsy Forceps), by Region - Global Forecast 2021-2028
Coronary Stents Market - Coronary Stents Market Analysis By Product (Bare Metal Stents, Drug Eluting Stents, Bio-absorbable Stents) & Region - Global Forecast 2021 to 2028
Oligonucleotide Synthesis Market - Oligonucleotide Synthesis Market Analysis by Product (Reagents & Consumables, Equipment, Synthesized Oligonucleotides, DNA Oligonucleotides, RNA Oligonucleotides, Others), by Application (Research, Therapeutics), by End-User (Biotechnology & Pharmaceutical Companies, Research Institutes, Diagnostic Laboratories) & by Region- 2022-2032
Bipolar Disorder Therapeutics Market - Bipolar Disorder Therapeutics Market Analysis, By Drug Class (Antipsychotics Drugs, Anticonvulsants, Mood Stabilizers, Antidepressant Drugs, Anti-anxiety Drugs) - Global Market Insights 2022 to 2026
Sepsis Diagnostics Market - Sepsis Diagnostics Market Analysis by Product (Blood Culture Media, Instruments and Assays & Reagents), Method (Conventional Sepsis Diagnostics, Automated Sepsis Diagnostics, Pathogen, Gram-negative Bacterial Sepsis, Gram-positive Bacterial Sepsis, Fungal Sepsis and Other Pathogens), Technology (Microbiology, Molecular Diagnostics, Immunoassays and Other Technologies) and Region Forecast- 2022-2032
NGS Sample Preparation Market - NGS Sample Preparation Market Analysis by Product Type (NGS Sample Preparation Instruments and NGS Sample Preparation Kits and Reagents & Consumables), Application (NGS Sample Preparation for Drug & Biomarker Discovery, NGS Sample Preparation for Diagnostics, NGS Sample Preparation for Precision Medicines and Others (Agriculture and Animal Research)), End User (Hospitals & Diagnostic Centers, Biotechnology & Pharmaceutical Companies, Academic & Research Institutes and Others (CROs and CMOs) and Region Forecast- 2022-2032
Antibody Drug Conjugates Contract Market - Antibody Drug Conjugates Contract Market by Condition Type (Myeloma, Lymphoma, Breast Cancer, Other Condition Types), Application Type (Cleavable Linker, Non-cleavable Linker), and By Region- 2022 to 2032
Cochlear Implant Market - Cochlear Implant Market by Fitting Type (Unilateral Implants, Bilateral Implants), End Use (Adult, Pediatric), and Region (North America, Latin America, Europe, APAC, and MEA) from 2022 to 2032
Lateral Flow Assays Market - Lateral Flow Assay Market by Product Type (Lateral Flow Readers, Digital/Mobile Readers, Benchtop Readers, Kits & Reagents), Application (Drug Development & Quality Testing, Clinical Testing etc.), Technique End-use, and Region -2022 to 2032
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we'll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-158
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.